Russia's Sputnik V has shown 91.4% efficacy, according to the final control point analysis of data obtained 21 days after administering the first dose.
"The calculation was based on the analysis of data of volunteers (n = 22 714) who received both the first and second doses of the Sputnik V vaccine or placebo at the third and final control point of 78 confirmed cases in accordance with the Phase III clinical trials protocol," read a statement by Sputnik.
A press release released by the candidate stated that the advance to the third and final statistically significant representative control point allowed for the final proof of the efficacy of the vaccine of over 90%.
VIDEO: Messi Mania Hits Kolkata! Fans Throng Airport, Streets Crowded As Fans Set Off Fireworks To Welcome Argentina Legend
Mumbai News: BMC Puts Prime 23,822 Sq m Lower Parel Land Parcel On Lease After Supreme Court Win; Expects ₹1,348 Crore Revenue
Bombay HC Grants Bail To Alleged LeT Operative Accused Of 2010 Nashik Reconnaissance Case; Cites Over 10 Years In Jail And Trial Delays
Bombay HC: Magistrate Cannot Order Blocking Of Online Content Under IT Act; Upholds Stay On Contempt Plea Against Google
